{{Rsnum
|rsid=315721
|Gene=LCP2
|Chromosome=5
|position=170288034
|Orientation=plus
|GMAF=0.3421
|Gene_s=LCP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 53.1 | 40.7 | 6.2
| HCB | 51.1 | 40.1 | 8.8
| JPT | 27.4 | 50.4 | 22.1
| YRI | 33.3 | 47.6 | 19.0
| ASW | 31.6 | 52.6 | 15.8
| CHB | 51.1 | 40.1 | 8.8
| CHD | 49.1 | 39.8 | 11.1
| GIH | 40.6 | 48.5 | 10.9
| LWK | 33.6 | 56.4 | 10.0
| MEX | 39.7 | 44.8 | 15.5
| MKK | 41.7 | 46.8 | 11.5
| TSI | 38.2 | 46.1 | 15.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23613720
|Title=Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}